Metastatic bone disease: Pathogenesis and therapeutic options
نویسندگان
چکیده
منابع مشابه
Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options.
Secondary hyperparathyroidism (SHPT) is a challenge frequently encountered in the management of patients with chronic kidney disease (CKD). Downregulation of the parathyroid vitamin D and calcium-sensing receptors represent critical steps that lead to abnormalities in mineral metabolism: high phosphate, low calcium, and vitamin D deficiency. These imbalances result in parathyroid hyperplasia an...
متن کاملMetastatic Extramammary Paget’s Disease: Pathogenesis and Novel Therapeutic Approach
Extramammary Paget's disease (EMPD) is a rare, slow-growing, cutaneous adenocarcinoma that usually originates in the anogenital area and axillae outside the mammary glands. EMPD mostly progresses slowly and is often diagnosed as carcinoma in situ; however, upon becoming invasive, it promptly and frequently metastasizes to regional lymph nodes, leading to subsequent distant metastasis. To date, ...
متن کاملCorrigendum: Metastatic Extramammary Paget’s Disease: Pathogenesis and Novel Therapeutic Approach
[This corrects the article on p. 38 in vol. 8, PMID: 29503810.].
متن کاملAcquired facial lipoatrophy: pathogenesis and therapeutic options
Facial lipoatrophy refers to the loss of subcutaneous fat tissue presenting by flattening or indentation of convex contour of the face. Facial lipoatrophy is a feature of the normal ageing process. It may be also a manifestation of chronic diseases, most frequently it affects HIV-infected individuals treated with highly active antiretroviral therapy (HAART) and may constitute a complication of ...
متن کاملMetachromatic leukodystrophy: genetics, pathogenesis and therapeutic options.
UNLABELLED Metachromatic leukodystrophy is a lysosomal storage disease caused by the deficiency of arylsulphatase A (ASA). This leads to storage of the membrane lipid sulphatide, which is abundant in myelin. A pathological hallmark of the disease is demyelination, causing various and ultimately lethal neurological symptoms. Today more than 110 mutations in the ASA gene have been identified, of ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Bone Oncology
سال: 2019
ISSN: 2212-1374
DOI: 10.1016/j.jbo.2018.10.004